(Reuters) -Tylenol maker Kenvue said on Monday that Johnson & Johnson will sell its remaining 9.5% stake in the company, ...
Tylenol maker Kenvue said on Monday that Johnson & Johnson will offload its entire 9.5% stake in the company, about a year ...
, opens new tab will sell its remaining 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer health business. Based on Kenvue stock's last ...
After Johnson & Johnson's consumer healthcare spinoff last year—and its subsequent reduction in holdings in the new ...
London: Tylenol maker Kenvue said on Monday that Johnson & Johnson will sell its remaining 9.5 per cent stake in the company, about a year after the healthcare conglomerate spun off and listed its ...
By Dean Seal Johnson & Johnson plans to unload its remaining 9.5% stake in Kenvue in a public offering set about a year after it started splitting ...